American Association for Cancer Research
Browse
10780432ccr113131-sup-relatedarticle.html (0.8 kB)

Related Article from Does PTEN Loss Impair DNA Double-Strand Break Repair by Homologous Recombination?

Download (0.8 kB)
dataset
posted on 2023-03-31, 16:42 authored by Clayton R. Hunt, Arun Gupta, Nobuo Horikoshi, Tej K. Pandita
Related Article from Does PTEN Loss Impair DNA Double-Strand Break Repair by Homologous Recombination?

History

ARTICLE ABSTRACT

The tumor suppressor PTEN is frequently lost in cancer cells, resulting in altered radiation and drug sensitivity. However, the role of PTEN in DNA repair is controversial. Detailed studies in prostate cancer cells now indicate PTEN does not regulate RAD51 expression or homologous recombination and is not a biomarker for PARP inhibitor sensitivity. Clin Cancer Res; 18(4); 920–2. ©2011 AACR.

Usage metrics

    Clinical Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC